These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8110662)

  • 1. Structure design: an artificial intelligence-based method for the design of molecules under geometrical constraints.
    Cohen AA; Shatzmiller SE
    J Mol Graph; 1993 Sep; 11(3):166-73. PubMed ID: 8110662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecule evoluator. An interactive evolutionary algorithm for the design of drug-like molecules.
    Lameijer EW; Kok JN; Bäck T; Ijzerman AP
    J Chem Inf Model; 2006; 46(2):545-52. PubMed ID: 16562982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fast and efficient method for 2D and 3D molecular shape description.
    Bemis GW; Kuntz ID
    J Comput Aided Mol Des; 1992 Dec; 6(6):607-28. PubMed ID: 1291629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPROUT: a program for structure generation.
    Gillet V; Johnson AP; Mata P; Sike S; Williams P
    J Comput Aided Mol Des; 1993 Apr; 7(2):127-53. PubMed ID: 8320553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of different software implementations on the performance of the Maxmin method for diverse subset selection.
    Schmuker M; Givehchi A; Schneider G
    Mol Divers; 2004; 8(4):421-5. PubMed ID: 15612646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated conformational analysis: algorithms for the efficient construction of low-energy conformations.
    Leach AR; Prout K; Dolata DP
    J Comput Aided Mol Des; 1990 Sep; 4(3):271-82. PubMed ID: 2280264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm.
    Bai Q; Tan S; Xu T; Liu H; Huang J; Yao X
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32778891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated site-directed drug design using molecular lattices.
    Lewis RA; Roe DC; Huang C; Ferrin TE; Langridge R; Kuntz ID
    J Mol Graph; 1992 Jun; 10(2):66-78, 106. PubMed ID: 1637751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting ECG data by integrating statistical and artificial intelligence tools.
    Tatara E; Cinar A
    IEEE Eng Med Biol Mag; 2002; 21(1):36-41. PubMed ID: 11935986
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative structure-activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method.
    Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):844-53. PubMed ID: 20429783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of equilibrium constants using automated group contribution methods.
    Forsythe RG; Karp PD; Mavrovouniotis ML
    Comput Appl Biosci; 1997 Oct; 13(5):537-43. PubMed ID: 9367126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated approach for designing medical decision support systems with knowledge extracted from clinical databases by statistical methods.
    Krusinska E; Babic A; Chowdhury S; Wigertz O; Bodemar G; Mathiesen U
    Proc Annu Symp Comput Appl Med Care; 1991; ():353-7. PubMed ID: 1807621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRO-LIGAND: an approach to de novo molecular design. 3. A genetic algorithm for structure refinement.
    Westhead DR; Clark DE; Frenkel D; Li J; Murray CW; Robson B; Waszkowycz B
    J Comput Aided Mol Des; 1995 Apr; 9(2):139-48. PubMed ID: 7608745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of fuzzy classifier for diabetes disease using Modified Artificial Bee Colony algorithm.
    Beloufa F; Chikh MA
    Comput Methods Programs Biomed; 2013 Oct; 112(1):92-103. PubMed ID: 23932385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DISE: directed sphere exclusion.
    Gobbi A; Lee ML
    J Chem Inf Comput Sci; 2003; 43(1):317-23. PubMed ID: 12546567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DBMAKER: a set of programs to generate three-dimensional databases based upon user-specified criteria.
    Ho CM; Marshall GR
    J Comput Aided Mol Des; 1995 Feb; 9(1):65-86. PubMed ID: 7751871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABGEN: a knowledge-based automated approach for antibody structure modeling.
    Mandal C; Kingery BD; Anchin JM; Subramaniam S; Linthicum DS
    Nat Biotechnol; 1996 Mar; 14(3):323-8. PubMed ID: 9630894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic algorithm for the automated generation of molecules within constraints.
    Glen RC; Payne AW
    J Comput Aided Mol Des; 1995 Apr; 9(2):181-202. PubMed ID: 7608749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated site-directed drug design: a method for the generation of general three-dimensional molecular graphs.
    Lewis RA
    J Mol Graph; 1992 Sep; 10(3):131-43. PubMed ID: 1467330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovering metric temporal constraint networks on temporal databases.
    Álvarez MR; Félix P; Cariñena P
    Artif Intell Med; 2013 Jul; 58(3):139-54. PubMed ID: 23660232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.